MSAT Specialist
Company: Civica Rx
Location: Petersburg
Posted on: November 10, 2024
|
|
Job Description:
About Civica: Over the past two decades, shortages of generic,
injectable medications critical to the lifesaving work of hospitals
in the United States have become commonplace and have reached an
all time high. Over 300 essential medications are reported to be in
shortage, according to industry and FDA reports. "Race to the
bottom" pricing of mostly sterile injectable medications,
manufacturing challenges and predatory pricing are both the causes
and results. Who suffers most? Patients. Civica is a 501(c)(4)
social welfare organization established in 2018 by health systems
(CommonSpirit Health, HCA Healthcare, Intermountain Healthcare,
Mayo Clinic, Providence St. Joseph Health, SSM Health, and Trinity
Health) and philanthropies (Gary and Mary West Foundation, Laura
and John Arnold Foundation, and Peterson Center on Healthcare) to
reduce chronic generic drug shortages and related high prices in
the United States. An experienced team of health care and
pharmaceutical industry leaders leads the organization. Today, more
than 55 health systems have joined Civica. They represent over
1,500 hospitals and over 30 percent of all U.S. hospital beds.
Civica has also supplied the U.S. Department of Veteran's Affairs,
the U.S. Department of Defense, and the U.S. Strategic National
Stockpile of essential medicines. Since established, the #1 Policy
for the Civica team has been "Do What Is in the Best Interest of
Patients." Civica has expanded its mission beyond the hospital
setting to include lowering the cost of medications at the pharmacy
counter. It has launched a sister organization, CivicaScript, to
enter the retail pharmacy market partnering with Blue Cross Blue
Shield entities and others with the goal of reducing select high
cost generic drugs where market forces are not working to control
drug costs. More recently, Civica announced plans to develop,
manufacture and deliver affordable biosimilar insulin, The
consistent availability of affordable insulin will benefit people
who ration their care or who have been forced to choose between
this life-sustaining medicine and living expenses. Those who are
uninsured or underinsured often pay the most out of pocket for
their medications. Long- and short-acting insulins will be produced
and available in both vials and pre-filled pens - at no more than
$30 per vial and no more than $55 for a pack of five pens. Learn
more about Civica's plans and progress at www.civicarx.org Job
Description The Manufacturing, Science and Technology (MSAT)
Specialist will join the Civica, Inc. ("Civica") MSAT organization
at the Petersburg, Virginia site by bringing their knowledge and
experience in service to patients and pursuit of excellence in
quality and compliance. The Petersburg site serves as Civica's new
fill finish facility dedicated to the manufacture and supply of
essential generic sterile injectable medications. The MSAT
Specialist will conduct technical investigations and process
support activities. Reporting to the Director, MSAT, this role will
closely work with Civica's Manufacturing and Engineering teams and
lead risk assessment and investigations. Essential Duties and
Responsibilities:
Keywords: Civica Rx, Norfolk , MSAT Specialist, Other , Petersburg, Virginia
Click
here to apply!
|